✦ LIBER ✦

Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy

✍ Scribed by Lei Qiu, Xi Gong, Qianli Wang, Jie Li, Honggang Hu, Qiuye Wu, Junping Zhang, Zhongwu Guo

Book ID: 118781358
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 589 KB
Volume: 61
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-012-1224-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Immunotherapy for C

ChemInform Abstract: Immunotherapy for Cancer: Synthetic Carbohydrate-Based Vaccines

✍ Therese Buskas; Pamela Thompson; Geert-Jan Boons 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

Recent advances in developing synthetic

Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies

✍ Hevey, Rachel; Ling, Chang-Chun 📂 Article 📅 2012 🏛 Future Science 🌐 English ⚖ 799 KB

Combining cytokine-induced killer cells

Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?

✍ Sharmilan Thanendrarajan; Michael Nowak; Hinrich Abken; Ingo G.H. Schmidt-Wolf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Synthetic luteinizing hormone releasing

Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy

✍ Connie L Finstad; Chang Yi Wang; Jacek Kowalski; Meilun Zhang; Ming Lie Li; Xuan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Adjuvant engineering for cancer immunoth

Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion

✍ Takashi Akazawa; Norimitsu Inoue; Hiroaki Shime; Ken Kodama; Misako Matsumoto; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

Combined antiestrogen and cytotoxic ther

Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer a prospective, randomized trial

✍ Gabriel N. Hortobagyi; Aman U. Buzdar; Debra Frye; Verena Hug; Giuseppe Fraschin 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

One hundred thirty-three consecutive, previously untreated patients who had metastatic breast cancer were treated with a combination of 5-fluorouraci1, doxorubicin (Adriamycin), and cyclophosphamide (FAC). They were randomly assigned to receive nonspecific immunotherapy with a heptavalent pseudomona